Weight loss agent showed CV safety in high-risk patients with overweight or obesity

3' education - Aug. 26, 2018 - Dr. Erin Bohula, Boston, MA, US

Educational information

This 3-minute education provides a summary of just presented scientific data, recorded during the ESC 2018 congress. The objective is to provide a brief commentary and potential implications of these findings.

Faculty

Dr. Erin Bohula is Instructor of Medicine, Harvard Medical School, Brigham and Women’s Hospital, Boston, MA, USA.

Disclosures

The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme. PACE-cme did not receive financial support for the production of this 3-minute education.

Read our summary of the CAMELLIA-TIMI 61 trial

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.